Beta-Blocker Discontinuation Is Safe for Stable Heart Attack Patients: SMART-DECISION Trial

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650.00 annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

Beta-Blocker Discontinuation Is Safe for Stable Heart Attack Patients: SMART-DECISION Trial

Posted: 03/30/2026
Author:
Bailey G. Salimes, CRTonline.org
2026 Heart Failure Pharma Late-Breaking Trials ACC Heart Failure Meetings News Conference News Articles

Within 1-year after heart attack, outcomes are similar in patients who discontinue beta-blocker therapy versus patients who continue taking beta-blockers, demonstrating noninferiority in results from the SMART-DECISION trial.

Most Viewed Pages

VA Study Shows Need for Improvement in Distribution of Quadruple Therapy in Patients With HFrEF

AI-Assisted Cardiac CT Identifies Patients at High Risk of Heart Failure

IVUS- and Angiography-Guided PCI Have Similar Outcomes in High-Risk, Complex PCI: IVUS-CHIP Study

Live Case from MedStar Washington Hospital Center | Washington, DC

Contemporary Trends, Characteristics, and Outcomes of Patients Undergoing PCI for Stent Thrombosis

Invalid Configuration Data. Please look into Pipeline and other configurations.

No record found for the searched term.

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

Beta-Blocker Discontinuation Is Safe for Stable Heart Attack Patients: SMART-DECISION Trial

Most Viewed Pages

Explore the Site

Stay Connected